Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
Knn3M6Q2Zh5bYh8N